MedPath

To study and compare the effect of preoperative nebulized Magnesium sulphate versus Lignocaine in reducing the incidence of post-operative sore throat in patients undergoing surgery under general anaesthesia

Phase 1/2
Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2024/02/062836
Lead Sponsor
Supriya
Brief Summary

We will be nebulizing patients with Magnesium sulfate 250mg and Lignocaine 100 mg over 15 minutes and then follow up patients for developing pharyngolaryngeal complications

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

ASA class I-II BMI 18.5-29.9 Undergoing elective surgeries requiring general anaesthesia with cuffed ETT of duration 60-120 minutes.

Exclusion Criteria

Patients refusal for participation in study,hemodynamically unstable pt,history of hypersensitivity to drug used,history of active or recent URTI(last 6 weeks),trauma during intubation,patients on analgesics or steroids.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate & compare the effectiveness of nebulized Magnesium sulfate & Lignocaine in:2 hours,6 hours,12 hours, 24 hours, 48 hours
a.Extubation quality score using 5 points extubation quality score.2 hours,6 hours,12 hours, 24 hours, 48 hours
b.Post extubation airway related adverse effects like cough,sore throat,hoarseness.2 hours,6 hours,12 hours, 24 hours, 48 hours
Secondary Outcome Measures
NameTimeMethod
1.To access the hemodynamic parameter during surgery & extubation.2.To access the airway dynamics during surgery & extubation.

Trial Locations

Locations (1)

Dr Rajendra Prasad Government Medical College Tanda Kangra Himachal Pradesh

🇮🇳

Kangra, HIMACHAL PRADESH, India

Dr Rajendra Prasad Government Medical College Tanda Kangra Himachal Pradesh
🇮🇳Kangra, HIMACHAL PRADESH, India
Dr Supriya
Principal investigator
8580991452
Supriyathakur65@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.